MACSF

COMMUNIQUÉS West-GlobeNewswire

Cytovance® Biologics Inc. appoints Dr. Jesse McCool as Chief Technology Officer
27/06/2019
Cytovance ® Biologics Inc. announced that Dr. Jesse McCool will serve the company as CTO, effective June 27, 2019 OKLAHOMA CITY, June 27, 2019 (GLOBE NEWSWIRE) -- Cytovance ® Biologics, a leading biopharmaceutical [...]
Allergy Therapeutics plc - Trading Update and Successful Litigation Settlement
27/06/2019
Allergy Therapeutics plc (“Allergy Therapeutics” or the “Group”) Trading Update and Successful Litigation Settlement 2019 full year earnings expected to be ahead of market expectations 27 June 2019 Allergy Therapeutics [...]
Medtronic Completes Acquisition of Titan Spine
27/06/2019
Acquisition Accelerates Medtronic’s Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions DUBLIN, June 27, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader [...]
Driven Deliveries Inc. Partners with 10 Brands for Driven’s Brand to Consumer Cannabis Delivery Service
27/06/2019
SAN DIEGO, June 27, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc. (DRVD), the world’s first publicly traded cannabis delivery company, announced today that the company has signed 10 brands as part of Driven’s [...]
New Data Published in American Journal of Psychiatry Further Substantiates BrainsWay’s Deep TMS System for the Treatment of Patients with Obsessive Compulsive Disorder
27/06/2019
- First non-invasive device for OCD achieves 45% response rate among patients after one month follow up, and significantly reduced symptoms scores compared with placebo - HACKENSACK, N.J., June 27, 2019 (GLOBE NEWSWIRE [...]
Aleafia Health Announces Closing of $40.25 Million Public Offering, Including Full Exercise of the Over-Allotment Option
27/06/2019
TORONTO, June 27, 2019 (GLOBE NEWSWIRE) -- (TSX: ALEF) (OTC: ALEAF) (FRA:ARAH) Aleafia Health Inc. (“ Aleafia Health ” or the “ Company ”) is pleased to announce that it has closed its previously announced public [...]
Chembio Diagnostics Receives CE Mark for its Point-of-Care Multiplex Test for Zika, Dengue and Chikungunya
27/06/2019
MEDFORD, N.Y. , June 27, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that is has obtained a CE mark for [...]
INmune Bio Announces Publication of Data on INKmune Primed NK cells in Peer-Reviewed Journal PLOS ONE
27/06/2019
LA JOLLA, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunotherapy company developing treatments that harness the patient’s innate immune system to fight disease, announced today that [...]
Adamis Pharmaceuticals Provides Update on Litigation with kaléo Inc.
27/06/2019
SAN DIEGO, June 27, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided an update on the litigation with kaléo Inc. regarding kaléo’s claims of patent infringement relating to [...]
Qrons Appoints Veteran U.S. Based Biotech Executive Dr. John N. Bonfiglio to Lead IND and Capital Markets Related Activities
27/06/2019
New York, NY, June 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTC: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the treatment of [...]
Chicago-based Psychiatrist, Dr. Fabian Carbonell, Debuts Innovative FDA-Cleared Treatment for Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
27/06/2019
Dr. Carbonell joins practices around the country that have adopted BrainsWay’s revolutionary Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for MDD and OCD, providing patients in the Chicago area access to [...]
Kannalife, Inc. to Present Breakthrough CIPN Study Findings on the Comparison of KLS-13019 to CBD at 29th Annual International Cannabinoid Research Society Conference
27/06/2019
DOYLESTOWN, Pa., June 27, 2019 (GLOBE NEWSWIRE) -- Kannalife, Inc. (OTC: KLFE) (“Kannalife” or “the Company”), a biopharmaceutical company focused on the research, development and discovery of natural and novel [...]
Alphatec Announces Organizational and Corporate Updates
27/06/2019
Appointment of Karen McGinnis to Board of Directors Inclusion in Russell 2000 ® Index Drawdown on Squadron Credit Facility CARLSBAD, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “ [...]
OLAH Healthcare Technology welcomes Max Immelman as Senior Sales Executive
27/06/2019
COLUMBUS, Ohio, June 27, 2019 (GLOBE NEWSWIRE) -- Max Immelman recently joined OLAH Healthcare Technology as Senior Sales Executive. With more than 18 years of experience in healthcare information technology, Immelman [...]
RenovaCare Appoints VP to Expand and Accelerate Intellectual Property and Licensing
27/06/2019
SCOTTSDALE, Ariz., June 27, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com ), developer of the SkinGun™ and other patented technologies for spraying a patient’s own stem cells onto burns [...]
Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
27/06/2019
CALGARY, Alberta, June 27, 2019 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today that it has dosed the first patient in a Phase [...]
Spring Bank to Present Pre-Clinical Data on Its Novel STING Antagonist Program at The Autoimmunity Conference
27/06/2019
HOPKINTON, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Evoke Pharma Requests Type A FDA Meeting to Plan for Resubmission of Gimoti™ NDA
27/06/2019
SOLANA BEACH, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has [...]
Hemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical Trial
27/06/2019
CALGARY, Alberta, June 27, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has enrolled a total of forty (40) patients in its [...]

Pages